Article Information
History
- March 15, 2021.
Article Versions
- Version 1 (February 10, 2021 - 07:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammad A. Dabbah1,
- Angus B. Reed1,
- Adam T.C. Booth1,
- Arrash Yassaee1,2,
- Alex Despotovic1,3,
- Benjamin Klasmer1,
- Emily Binning1,
- Mert Aral1,
- David Plans*,1,4,
- Alain B. Labrique5 and
- Diwakar Mohan5
- 1Huma Therapeutics Limited, London, United Kingdom
- 2Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, United Kingdom
- 3Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 4University of Exeter, SITE, Exeter, United Kingdom
- 5Johns Hopkins Bloomberg School Public Health, Baltimore, Maryland, United States
- ↵*Corresponding Author:
David Plans (david.plans{at}huma.com)
Posted March 15, 2021.
Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study
